<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-149589" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Mohs Micrographic Surgery Anticoagulants And Hemostatic Agents Impact</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Modiri</surname>
            <given-names>Omeed</given-names>
          </name>
          <aff>University of California, Los Angeles</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Davis</surname>
            <given-names>Jeremy</given-names>
          </name>
          <aff>University of California Los Angeles</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Omeed Modiri declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jeremy Davis declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>10</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-149589.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Mohs micrographic surgery (MMS) is a specialized dermatological surgical technique frequently employed when treating non-melanoma skin cancers. MMS is considered a safe surgical procedure with a low overall risk of perioperative complications.<xref ref-type="bibr" rid="article-149589.r1">[1]</xref>&#x000a0;A minor amount of intraoperative bleeding is expected during MMS; such bleeding is easily controlled with a combination of electrocautery, gentle mechanical pressure, or topical hemostatic agents. However, rare occurrences of more severe perioperative bleeding&#x000a0;may&#x000a0;lead to hematoma formation, wound dehiscence, and potential loss of grafts or flaps.</p>
        <p>Patients undergoing MMS during the concomitant use of antiplatelet or anticoagulant therapy are at increased risk of perioperative bleeding and subsequent complications.<xref ref-type="bibr" rid="article-149589.r1">[1]</xref><xref ref-type="bibr" rid="article-149589.r2">[2]</xref>&#x000a0;Direct-acting oral agent (DOAC) anticoagulant therapy is increasing in frequency and may pose additional perioperative bleeding risks.<xref ref-type="bibr" rid="article-149589.r3">[3]</xref>&#x000a0;</p>
        <p>A comprehensive understanding of the risks associated with antiplatelet and anticoagulant medications, partnered with diligent perioperative management and meticulous attention to intraoperative hemostasis, is necessary to reduce complications in patients undergoing MMS during concomitant anticoagulation therapy. This activity will review the current recommendations for the perioperative management of&#x000a0;these patients, including the risks, benefits, and technical considerations.</p>
      </sec>
      <sec id="article-149589.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Patients undergoing MMS commonly have medical comorbidities with the potential to impact surgical outcomes. Of particular interest is the widespread&#x000a0;utilization of antiplatelet and anticoagulant therapies&#x000a0;that may increase the frequency of bleeding-related complications. An estimated 25% to 38% of patients undergoing dermatologic surgery are on at least one anticoagulant or antiplatelet agent during the perioperative period.<xref ref-type="bibr" rid="article-149589.r4">[4]</xref>&#x000a0;While the consensus is that anticoagulation therapies are safe to continue during the perioperative period, the MMS practitioner must be aware of their use and understand the associated surgical risks.<xref ref-type="bibr" rid="article-149589.r5">[5]</xref></p>
        <p>Many studies have investigated the impact of commonly used antithrombotic agents&#x000a0;on the risk of hemorrhagic complications in MMS.<xref ref-type="bibr" rid="article-149589.r6">[6]</xref>&#x000a0;The risks of perioperative bleeding-related complications vary with specific drug classes and combination therapies.</p>
        <p>
<bold>Antiplatelet&#x000a0;Medications</bold>
</p>
        <p>Antiplatelet agents are a class of pharmaceuticals that inhibit or decrease platelet aggregation,&#x000a0;thereby increasing bleeding time. Aspirin and clopidogrel are among the most common antiplatelet agents prescribed to patients commonly undergoing MMS.<xref ref-type="bibr" rid="article-149589.r3">[3]</xref><xref ref-type="bibr" rid="article-149589.r7">[7]</xref>&#x000a0;Studies have consistently demonstrated that aspirin&#x000a0;monotherapy does not increase the risk of postoperative bleeding and is not associated with a significant increase in hemorrhagic complications in patients undergoing cutaneous surgery, including MMS.<xref ref-type="bibr" rid="article-149589.r8">[8]</xref><xref ref-type="bibr" rid="article-149589.r9">[9]</xref>&#x000a0;The impact of clopidogrel monotherapy on bleeding risks is less conclusive; studies indicate either no increased or a mildly increased risk of perioperative complications in dermatologic surgery compared to patients not taking antiplatelet and anticoagulant medications.<xref ref-type="bibr" rid="article-149589.r10">[10]</xref><xref ref-type="bibr" rid="article-149589.r7">[7]</xref><xref ref-type="bibr" rid="article-149589.r11">[11]</xref><xref ref-type="bibr" rid="article-149589.r12">[12]</xref><xref ref-type="bibr" rid="article-149589.r13">[13]</xref>&#x000a0;</p>
        <p>However, when clopidogrel and aspirin are combined with other agents, there appears to be a synergistic effect on the risk of bleeding-associated complications. A study revealed that multidrug anticoagulation regimens containing clopidogrel conferred&#x000a0;significantly increased risks of bleeding-related complications compared to patients on no anticoagulation&#x000a0;or aspirin monotherapy.<xref ref-type="bibr" rid="article-149589.r11">[11]</xref>&#x000a0;The same analysis revealed significantly increased complications in patients on dual antiplatelet therapy with clopidogrel and aspirin compared to patients on aspirin monotherapy. Other studies corroborate this increased risk from multidrug anticoagulation regimens.<xref ref-type="bibr" rid="article-149589.r7">[7]</xref><xref ref-type="bibr" rid="article-149589.r14">[14]</xref></p>
        <p>
<bold>Anticoagulant&#x000a0;Medications</bold>
</p>
        <p>Oral anticoagulants that directly target the coagulation cascade rather than platelet formation are also of concern. Warfarin is a well-established vitamin K antagonist and remains a commonly prescribed anticoagulant in patients undergoing MMS.<xref ref-type="bibr" rid="article-149589.r3">[3]</xref>&#x000a0;A recent meta-analysis revealed that patients undergoing MMS or excisional treatment of skin cancers were 7 times more likely to&#x000a0;have bleeding-related complications than patients not taking anticoagulant therapy.<xref ref-type="bibr" rid="article-149589.r15">[15]</xref>&#x000a0;A study by Nast et al revealed a significant increase in minor and moderate bleeding in patients taking warfarin compared to controls.<xref ref-type="bibr" rid="article-149589.r8">[8]</xref>&#x000a0;However, some studies indicate that warfarin&#x000a0;monotherapy is not associated with an increased risk of surgical complications.<xref ref-type="bibr" rid="article-149589.r16">[16]</xref>&#x000a0;</p>
        <p>While the data may be conflicting, there appears to be a slight increase in bleeding complications associated with warfarin in patients undergoing minor cutaneous surgery.<xref ref-type="bibr" rid="article-149589.r13">[13]</xref><xref ref-type="bibr" rid="article-149589.r17">[17]</xref>&#x000a0;This risk increases further when warfarin is combined with antiplatelet agents such as clopidogrel.<xref ref-type="bibr" rid="article-149589.r7">[7]</xref><xref ref-type="bibr" rid="article-149589.r11">[11]</xref><xref ref-type="bibr" rid="article-149589.r18">[18]</xref>&#x000a0;While an international normalized ratio (INR) may be obtained before surgery to assess the degree of anticoagulation in a patient undergoing cutaneous surgery while on warfarin monotherapy, several studies have shown no clear difference in bleeding complications based on preoperative INR value.<xref ref-type="bibr" rid="article-149589.r13">[13]</xref>&#x000a0;</p>
        <p>DOACs such asapixaban, rivaroxaban, and dabigatran are more effective in treating various cardiovascular conditions than traditional anticoagulants, and their use has increased accordingly.<xref ref-type="bibr" rid="article-149589.r3">[3]</xref>&#x000a0;Although the available data regarding hemorrhagic complications during concomitant use of these agents is limited, recent studies have demonstrated these agents may pose an even greater risk of hemorrhagic complications than previously studied agents. Anita et al showed a bleeding complication rate of 1.3% in patients on&#x000a0;DOACs undergoing MMS compared to a rate of 0.7% for all other patients, although this difference was not significant.<xref ref-type="bibr" rid="article-149589.r19">[19]</xref>&#x000a0;A&#x000a0;subsequent&#x000a0;study revealed that hemorrhagic complications in patients taking&#x000a0;DOACs were 7 times more likely compared to other anticoagulant classes.<xref ref-type="bibr" rid="article-149589.r18">[18]</xref></p>
      </sec>
      <sec id="article-149589.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Despite the increased risk of perioperative bleeding-related complications in patients undergoing MMS during concomitant anticoagulation therapy, the current recommendation is for patients to continue these agents during the perioperative period.<xref ref-type="bibr" rid="article-149589.r5">[5]</xref>&#x000a0;Discontinuation of clinically indicated anticoagulant or antiplatelet therapy is not without risk, and even brief interruptions in therapy may lead to catastrophic thrombotic events, the risk of which generally outweighs the increase in hemorrhagic complications of dermatologic surgery.<xref ref-type="bibr" rid="article-149589.r20">[20]</xref><xref ref-type="bibr" rid="article-149589.r21">[21]</xref>&#x000a0;Adverse effects related to antiplatelet or anticoagulant therapy are often minor and easily managed.<xref ref-type="bibr" rid="article-149589.r4">[4]</xref><xref ref-type="bibr" rid="article-149589.r22">[22]</xref>&#x000a0;While there is a relative increase in the risk of hemorrhagic complications attributable to antiplatelet or anticoagulant therapy, the absolute increase of these complications appears minimal, even for multidrug therapeutic regimens.<xref ref-type="bibr" rid="article-149589.r7">[7]</xref></p>
        <p>Given the current evidence, withholding antiplatelet and anticoagulant agents, including DOACS, before MMS is not routinely recommended.<xref ref-type="bibr" rid="article-149589.r18">[18]</xref>&#x000a0;Aspirin taken for analgesia instead of antiplatelet activity may be safely held in the perioperative period. Obtaining an INR for patients on warfarin is neither required nor common practice; if a preoperative INR indicates supratherapeutic treatment, consultation with the prescribing provider or postponing the MMS procedure is warranted.<xref ref-type="bibr" rid="article-149589.r23">[23]</xref></p>
      </sec>
      <sec id="article-149589.s4" sec-type="Other Issues">
        <title>Other Issues</title>
        <p>Mitigating the risks of hemorrhagic complications in the anticoagulated patient undergoing cutaneous surgery&#x000a0;requires meticulous attention to intraoperative technique and hemostasis.<xref ref-type="bibr" rid="article-149589.r24">[24]</xref>&#x000a0;Optimal intraoperative hemostasis provides several surgical benefits, including improved visualization of the surgical field, enhanced technical precision, reduced procedure time, and risk reduction.<xref ref-type="bibr" rid="article-149589.r25">[25]</xref><xref ref-type="bibr" rid="article-149589.r26">[26]</xref><bold>&#x000a0;</bold>Achieving intraoperative&#x000a0;hemostasis is especially important in the anticoagulated patient; several hemostatic modalities may be employed.<xref ref-type="bibr" rid="article-149589.r26">[26]</xref>&#x000a0;Electrosurgery is the most effective and commonly used method of achieving hemostasis in dermatologic surgery due to its ease of use, availability, and efficiency.<xref ref-type="bibr" rid="article-149589.r27">[27]</xref>&#x000a0;Hemostatic agents are also commonly utilized to achieve hemostasis in most dermatologic procedures and can be used as monotherapy or as part of a multimodal approach. Postoperative pressure dressings can be applied to assist with hemostasis as appropriate.<xref ref-type="bibr" rid="article-149589.r24">[24]</xref><xref ref-type="bibr" rid="article-149589.r28">[28]</xref></p>
        <p>While hemostatic agents can benefit hemostasis in anticoagulated patients, no single agent suits every clinical circumstance. Topical hemostatic agents used in cutaneous surgery include caustic, noncaustic, and physiologic agents,&#x000a0;each with a different mechanism of action.</p>
        <p>
<bold>Caustic Agents</bold>
</p>
        <p>Applying topical caustic hemostatic agents induces hemostasis by inducing tissue necrosis and protein coagulation,&#x000a0;leading to thrombus formation in the exposed cutaneous vessels.<xref ref-type="bibr" rid="article-149589.r29">[29]</xref>&#x000a0;Topical caustic hemostatic agents include ferric subsulfate, aluminum chloride, and zinc paste, commonly&#x000a0;used in superficial wounds created by shave or punch biopsies. Aluminum chloride is the most frequently used agent in this class due to its low cost, widespread availability, and minimal adverse effect profile characterized by mild pain and tissue irritation.<xref ref-type="bibr" rid="article-149589.r29">[29]</xref>&#x000a0;Ferric subsulfate, compounded as Monsel solution, is equally effective but has fallen out of favor somewhat due to the risk of permanent dyspigmentation from dermal iron placement.<xref ref-type="bibr" rid="article-149589.r30">[30]</xref>&#x000a0;The use of zinc paste, primarily composed of zinc chloride, was described by Frederic F. Mohs in&#x000a0;the chemical fixation of skin cancer. However, despite its anti-tumor properties, it is now infrequently used in the context of MMS.<xref ref-type="bibr" rid="article-149589.r29">[29]</xref></p>
        <p>
<bold>Noncaustic Agents</bold>
</p>
        <p>Noncaustic hemostatic agents include physical&#x000a0;substances that promote clot formation by providing a meshwork for platelet aggregation and coagulation.<xref ref-type="bibr" rid="article-149589.r31">[31]</xref>&#x000a0;Commonly used agents in this class include products containing gelatin, cellulose, collagen, or hydrophilic polymers, which can be formulated in vehicles such as powders and foams that are easy to apply. Although these agents are typically meant to dissolve over time, foreign body reactions have been reported.<xref ref-type="bibr" rid="article-149589.r32">[32]</xref>&#x000a0;Topical hemostatic agents&#x000a0;with collagen&#x000a0;are often bovine-derived and can lead to hypersensitivity reactions.<xref ref-type="bibr" rid="article-149589.r33">[33]</xref>&#x000a0;Additionally, applying cellulose agents has been associated with granulomatous reactions, delayed wound healing, and swelling at the application site.<xref ref-type="bibr" rid="article-149589.r31">[31]</xref></p>
        <p>
<bold>Physiologic Hemostatic Agents</bold>
</p>
        <p>The physiologic class of hemostatic agents mimics or enhances stages of the coagulation cascade following tissue application and includes thrombin derivatives, platelet gels, and fibrin sealants.<xref ref-type="bibr" rid="article-149589.r29">[29]</xref>&#x000a0;While physiologic agents are potent and effective at achieving hemostasis, this medication class is expensive and less frequently employed in dermatologic surgeries. Topical fibrin sealant has been associated with a hypersensitivity reaction in some patients and may rarely cause neurotoxicity.<xref ref-type="bibr" rid="article-149589.r27">[27]</xref>&#x000a0;Topical thrombin has been associated with an increased risk of coagulopathy due to subsequent antibody formation to bovine-derived thrombin after exposure; this adverse effect is uncommon.<xref ref-type="bibr" rid="article-149589.r34">[34]</xref></p>
        <p>
<bold>Areas of Ongoing Research</bold>
</p>
        <p>Brimonidine, an &#x003b1;-2 adrenergic agonist, may have a role as a hemostatic agent due to its vasoconstrictive properties. A small controlled study revealed the application of topical brimonidine gel before MMS resulted in decreased bleeding and a reduced need for electrocautery.<xref ref-type="bibr" rid="article-149589.r25">[25]</xref>&#x000a0;However, a later study reported altered mental status in patients following the application of topical brimonidine and ultimately recommended further evaluation of its safety before its routine use in MMS.<xref ref-type="bibr" rid="article-149589.r35">[35]</xref></p>
      </sec>
      <sec id="article-149589.s5" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Interprofessional collaboration among healthcare team members is essential to managing a patient undergoing MMS. These patients often inquire if it is necessary to stop antiplatelet or anticoagulation therapy before surgery; some patients preemptively hold these medications without discussion with the healthcare team. Nurses and medical assistants are essential in preoperative patient assessment and screening patients for antiplatelet or anticoagulant regimens.</p>
        <p>Adequately counseling patients&#x000a0;regarding the safety of perioperative antithrombotic therapy provides reassurance and minimizes the thrombotic risks associated with temporary discontinuation of the medication regimen. While consultation with the prescribing practitioner is rarely necessary, any concerns regarding the perioperative management of antithrombotic medications should be&#x000a0;discussed directly with the prescribing practitioner.</p>
        <p>Hemorrhagic complications associated with antithrombotic therapy can be minimized with meticulous attention to hemostasis and the postoperative application of a hemostatic dressing. Patients should receive education regarding postoperative wound care and the warning signs of hemorrhagic complications, including hematoma formation.</p>
      </sec>
      <sec id="article-149589.s6">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=149589&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=149589">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/149589/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=149589">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-149589.s7">
        <title>References</title>
        <ref id="article-149589.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ibrahim</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Nodzenski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Strasswimmer</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Albano</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Batra</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Behshad</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Benedetto</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Chilukuri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Crocker</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Crystal</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Dhir</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Faulconer</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Goodman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Greenbaum</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Hale</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Hanke</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Hruza</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Jacobson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kimyai-Asadi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kouba</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lahti</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Macias</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Monk</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Oganesyan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pennie</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pontius</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Posten</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Reichel</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Rohrer</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Rooney</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Poon</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bolotin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dubina</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pace</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Disphanurat</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kathawalla</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kakar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Veledar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Adverse events associated with mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centers.</article-title>
            <source>JAMA Dermatol</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>149</volume>
            <issue>12</issue>
            <fpage>1378</fpage>
            <page-range>1378-85</page-range>
            <pub-id pub-id-type="pmid">24080866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruiz-Salas</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sanmartin-Jim&#x000e9;nez</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Garc&#x000e9;s</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Vilarrasa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mi&#x000f1;ano-Medrano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Escutia-Mu&#x000f1;oz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fl&#x000f3;rez-Men&#x000e9;ndez</surname>
                <given-names>&#x000c1;</given-names>
              </name>
              <name>
                <surname>Artola-Igarza</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Alfaro-Rubio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Redondo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Delgado-Jim&#x000e9;nez</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Schmidt</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Allende-Markixana</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a Bracamonte</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>de la Cueva-Dobao</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ciudad</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Carnero-Gonz&#x000e1;lez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>V&#x000e1;zquez-Veiga</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Sambucety</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Estebaranz</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Botella-Estrada</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Sixto</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Martorell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Morales-Gordillo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Toll-Abell&#x000f3;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mayor-Arenal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Su&#x000e1;rez-Fern&#x000e1;ndez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sainz-Gaspar</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Descalzo</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Garcia-Doval</surname>
                <given-names>I</given-names>
              </name>
              <collab>REGESMOHS (Registro Espa&#x000f1;ol de Cirug&#x000ed;a de Mohs)</collab>
            </person-group>
            <article-title>Complications Associated with Mohs Micrographic Surgery: Data from the Nationwide Prospective Cohort REGESMOHS.</article-title>
            <source>Dermatology</source>
            <year>2022</year>
            <volume>238</volume>
            <issue>2</issue>
            <fpage>320</fpage>
            <page-range>320-328</page-range>
            <pub-id pub-id-type="pmid">34380138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brown</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Wilkerson</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Love</surname>
                <given-names>WE</given-names>
              </name>
            </person-group>
            <article-title>A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>72</volume>
            <issue>3</issue>
            <fpage>524</fpage>
            <page-range>524-34</page-range>
            <pub-id pub-id-type="pmid">25486915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Frech</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Dreyfuss</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nouri</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Perioperative anticoagulation recommendations for cutaneous oncologic surgery: a review of the literature.</article-title>
            <source>J Dermatolog Treat</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>33</volume>
            <issue>7</issue>
            <fpage>2940</fpage>
            <page-range>2940-2945</page-range>
            <pub-id pub-id-type="pmid">35775785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Otley</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Continuation of medically necessary aspirin and warfarin during cutaneous surgery.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>78</volume>
            <issue>11</issue>
            <fpage>1392</fpage>
            <page-range>1392-6</page-range>
            <pub-id pub-id-type="pmid">14601698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Greif</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Srivastava</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nijhawan</surname>
                <given-names>RI</given-names>
              </name>
            </person-group>
            <article-title>Postoperative bleeding complications associated with blood thinning agents during Mohs micrographic surgery: A retrospective cohort study.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>84</volume>
            <issue>1</issue>
            <fpage>225</fpage>
            <page-range>225-227</page-range>
            <pub-id pub-id-type="pmid">32526317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bordeaux</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Martires</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pattee</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Maloney</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>65</volume>
            <issue>3</issue>
            <fpage>576</fpage>
            <page-range>576-583</page-range>
            <pub-id pub-id-type="pmid">21782278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nast</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ernst</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rosumeck</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Erdmann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sporbeck</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Risk of complications due to anticoagulation during dermatosurgical procedures: a systematic review and meta-analysis.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>12</issue>
            <fpage>1603</fpage>
            <page-range>1603-9</page-range>
            <pub-id pub-id-type="pmid">25132203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Billingsley</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Maloney</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin, and nonsteroidal antiinflammatory agents. A prospective study.</article-title>
            <source>Dermatol Surg</source>
            <year>1997</year>
            <month>May</month>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>381</fpage>
            <page-range>381-3; discussion 384-5</page-range>
            <pub-id pub-id-type="pmid">9179249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kramer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hadad</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Westreich</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shalom</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Lack of complications in skin surgery of patients receiving clopidogrel as compared with patients taking aspirin, warfarin, and controls.</article-title>
            <source>Am Surg</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>76</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-4</page-range>
            <pub-id pub-id-type="pmid">20135932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cook-Norris</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Michaels</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Weaver</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Brewer</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Roenigk</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Otley</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulation.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>65</volume>
            <issue>3</issue>
            <fpage>584</fpage>
            <page-range>584-591</page-range>
            <pub-id pub-id-type="pmid">21514003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koenen</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kunte</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Breuninger</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Moehrle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bechara</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Schulze</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>L&#x000f6;sler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>L&#x000f6;ser</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Wetzig</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pappai</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rapprich</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wei&#x000df;</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Faulhaber</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Prospective multicentre cohort study on 9154 surgical procedures to assess the risk of postoperative bleeding - a DESSI study.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>724</fpage>
            <page-range>724-731</page-range>
            <pub-id pub-id-type="pmid">27976439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Isted</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Colville</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Bleeding on the cutting edge: A systematic review of anticoagulant and antiplatelet continuation in minor cutaneous surgery.</article-title>
            <source>J Plast Reconstr Aesthet Surg</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>71</volume>
            <issue>4</issue>
            <fpage>455</fpage>
            <page-range>455-467</page-range>
            <pub-id pub-id-type="pmid">29233507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shimizu</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Jellinek</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Dufresne</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Devarajan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Perlis</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Multiple antithrombotic agents increase the risk of postoperative hemorrhage in dermatologic surgery.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2008</year>
            <month>May</month>
            <volume>58</volume>
            <issue>5</issue>
            <fpage>810</fpage>
            <page-range>810-6</page-range>
            <pub-id pub-id-type="pmid">18423258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewis</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Dufresne</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>A meta-analysis of complications attributed to anticoagulation among patients following cutaneous surgery.</article-title>
            <source>Dermatol Surg</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>160</fpage>
            <page-range>160-4; discussion 164-5</page-range>
            <pub-id pub-id-type="pmid">18093204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alcalay</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Alkalay</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Controversies in perioperative management of blood thinners in dermatologic surgery: continue or discontinue?</article-title>
            <source>Dermatol Surg</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>30</volume>
            <issue>8</issue>
            <fpage>1091</fpage>
            <page-range>1091-4; discussion 1094</page-range>
            <pub-id pub-id-type="pmid">15274698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Syed</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Liao</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Pipitone</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gloster</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>A prospective assessment of bleeding and international normalized ratio in warfarin-anticoagulated patients having cutaneous surgery.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>51</volume>
            <issue>6</issue>
            <fpage>955</fpage>
            <page-range>955-7</page-range>
            <pub-id pub-id-type="pmid">15583588</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eilers</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Goldenberg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cowan</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Basu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Brian Jiang</surname>
                <given-names>SI</given-names>
              </name>
            </person-group>
            <article-title>A Retrospective Assessment of Postoperative Bleeding Complications in Anticoagulated Patients Following Mohs Micrographic Surgery.</article-title>
            <source>Dermatol Surg</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>44</volume>
            <issue>4</issue>
            <fpage>504</fpage>
            <page-range>504-511</page-range>
            <pub-id pub-id-type="pmid">29140870</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Antia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hone</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gloster</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Perioperative complications with new oral anticoagulants dabigatran, apixaban, and rivaroxaban in Mohs micrographic surgery: A retrospective study.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>77</volume>
            <issue>5</issue>
            <fpage>967</fpage>
            <page-range>967-968</page-range>
            <pub-id pub-id-type="pmid">29029905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kovich</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Otley</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>233</fpage>
            <page-range>233-7</page-range>
            <pub-id pub-id-type="pmid">12582394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy.</article-title>
            <source>Dermatol Surg</source>
            <year>2002</year>
            <month>Nov</month>
            <volume>28</volume>
            <issue>11</issue>
            <fpage>992</fpage>
            <page-range>992-8; discussion 998</page-range>
            <pub-id pub-id-type="pmid">12460291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kirkorian</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Siskind</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Marmur</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Perioperative management of anticoagulant therapy during cutaneous surgery: 2005 survey of Mohs surgeons.</article-title>
            <source>Dermatol Surg</source>
            <year>2007</year>
            <month>Oct</month>
            <volume>33</volume>
            <issue>10</issue>
            <fpage>1189</fpage>
            <page-range>1189-97</page-range>
            <pub-id pub-id-type="pmid">17903151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erickson</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Alam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Council</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Perioperative Practices in Dermatologic Surgery.</article-title>
            <source>Dermatol Surg</source>
            <year>2022</year>
            <month>Sep</month>
            <day>01</day>
            <volume>48</volume>
            <issue>9</issue>
            <fpage>924</fpage>
            <page-range>924-926</page-range>
            <pub-id pub-id-type="pmid">35862644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khalifeh</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Redett</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>The management of patients on anticoagulants prior to cutaneous surgery: case report of a thromboembolic complication, review of the literature, and evidence-based recommendations.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>118</volume>
            <issue>5</issue>
            <fpage>110e</fpage>
            <page-range>110e-117e</page-range>
            <pub-id pub-id-type="pmid">17016167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Kwak</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Randomized controlled pilot study of the preoperative use of brimonidine 0.33% topical gel for hemostasis in Mohs micrographic surgery.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>77</volume>
            <issue>6</issue>
            <fpage>1114</fpage>
            <page-range>1114-1118</page-range>
            <pub-id pub-id-type="pmid">29031658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Carlson</surname>
                <given-names>EO</given-names>
              </name>
              <name>
                <surname>Fathi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Undermining and Hemostasis.</article-title>
            <source>Dermatol Surg</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>41 Suppl 10</volume>
            <fpage>S201</fpage>
            <page-range>S201-15</page-range>
            <pub-id pub-id-type="pmid">26418686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Henley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brewer</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Newer hemostatic agents used in the practice of dermatologic surgery.</article-title>
            <source>Dermatol Res Pract</source>
            <year>2013</year>
            <volume>2013</volume>
            <fpage>279289</fpage>
            <pub-id pub-id-type="pmid">23997764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strickler</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bajaj</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mizuguchi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nijhawan</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Odueyungbo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ratner</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Preventing complications in dermatologic surgery: Presurgical concerns.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>84</volume>
            <issue>4</issue>
            <fpage>883</fpage>
            <page-range>883-892</page-range>
            <pub-id pub-id-type="pmid">33497750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palm</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Altman</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Topical hemostatic agents: a review.</article-title>
            <source>Dermatol Surg</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>431</fpage>
            <page-range>431-45</page-range>
            <pub-id pub-id-type="pmid">18248471</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amazon</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Rywlin</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Ferrugination caused by Monsel's solution. Clinical observations and experimentations.</article-title>
            <source>Am J Dermatopathol</source>
            <year>1980</year>
            <season>Fall</season>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>197</fpage>
            <page-range>197-205</page-range>
            <pub-id pub-id-type="pmid">7258552</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iyengar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yeager</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Ozog</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Update and Review of Bleeding Considerations in Dermatologic Surgery: Hemostatic Techniques and Treatment Strategies for Bleeding Complications.</article-title>
            <source>Dermatol Surg</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>46</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-212</page-range>
            <pub-id pub-id-type="pmid">31592926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glick</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Achieving hemostasis in dermatology-Part II: Topical hemostatic agents.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>172</fpage>
            <page-range>172-6</page-range>
            <pub-id pub-id-type="pmid">23984226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dhillon</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Fibrin sealant (evicel&#x000ae; [quixil&#x000ae;/crosseal&#x02122;]): a review of its use as supportive treatment for haemostasis in surgery.</article-title>
            <source>Drugs</source>
            <year>2011</year>
            <month>Oct</month>
            <day>01</day>
            <volume>71</volume>
            <issue>14</issue>
            <fpage>1893</fpage>
            <page-range>1893-915</page-range>
            <pub-id pub-id-type="pmid">21942978</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapman</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Singla</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Genyk</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>McNeil</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Renkens</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Weaver</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis.</article-title>
            <source>J Am Coll Surg</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>205</volume>
            <issue>2</issue>
            <fpage>256</fpage>
            <page-range>256-65</page-range>
            <pub-id pub-id-type="pmid">17660072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-149589.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shagalov</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Schleichert</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Association of Central Nervous System Depression With Topical Brimonidine When Used for Hemostasis: A Serious Adverse Event.</article-title>
            <source>JAMA Dermatol</source>
            <year>2017</year>
            <month>Jun</month>
            <day>01</day>
            <volume>153</volume>
            <issue>6</issue>
            <fpage>575</fpage>
            <page-range>575-577</page-range>
            <pub-id pub-id-type="pmid">28403392</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
